Background-Prior studies of the impact of psychiatric comorbidity on outcomes after acute myocardial infarction (AMI) have frequently relied on inpatient secondary diagnosis codes. This study compared associations between psychiatric comorbidity and AMI outcomes that were derived using secondary diagnosis codes and codes captured from prior outpatient encounters.
A number of studies over the past 2 decades have examined associations between the presence of psychiatric conditions and adverse outcomes from acute coronary syndromes. These analyses include prospective trials, 1-5 systematic reviews, 6 -9 and observational studies. 10 -20 Many of the latter observational analyses have relied on the use of large administrative (ie, claims) databases, either wholly or in part, as a means to identify patients with psychiatric comorbidities. Unfortunately, findings across these studies have revealed inconsistencies. For example, some studies have shown that patients with a wide spectrum of psychiatric comorbidities have a higher risk of death after an acute myocardial infarction (AMI), are less likely to undergo coronary revascularization, and are subject to lower quality of care, as assessed by a number of process measures (eg, use of appropriate medications). 14 -18 However, other studies have failed to detect such relationships. 19, 20 One potential explanation for the inconsistencies in the associations between AMI-related hospital outcomes and psychiatric comorbidities may be the methodological approach that has been used to identify psychiatric comorbidity from administrative databases. Therefore, we completed this study to directly evaluate how different approaches of identifying psychiatric comorbidities may impact AMI-related hospital outcomes for a range of psychiatric conditions. We studied a large cohort of patients admitted to Veterans Health Administration (VHA) facilities and identified psychiatric comorbidity using 2 different approaches that have been used in prior work-secondary diagnosis codes captured during the index hospitalization and diagnosis codes captured during prior outpatient encounters. Our objectives were to (1) compare the rates of psychiatric diseases identified by 2 approaches and (2) determine whether associations between psychiatric comorbidity and AMI-related hospital outcomes differed depending on which method of identifying psychiatric comorbidity was used. Based on these findings, we hoped to provide guidance for future studies on optimal approaches for identifying psychiatric comorbidity using administrative data.
Methods

Data Sources
Data were derived from 4 VHA sources: (1) the Patient Treatment File; (2) the Outpatient Care Files; (3) the Decision Support System laboratory files; and (4) the Vital Status File. The Patient Treatment File contains data on all hospitalizations in VHA hospital facilities nationally. Data elements include demographics, socioeconomic status, residential zip code, presence of disabilities related to military service; primary and secondary diagnoses and procedures, as defined by International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM) codes; admission sources (eg, transfer from another hospital, emergency room); admission and discharge times and dates; discharge destination and vital status. The Outpatient Care Files include administrative data on all outpatient encounters. Data elements include: dates of visits; type of clinic (eg, primary care, mental health); and ICD-9-CM diagnoses and procedures for each encounter. The Decision Support System laboratory files contain the results of selected all laboratory tests performed on an inpatient or outpatient basis. The Vital Status File was used to obtain dates of death of patients after hospital discharge; the validity of this file, with respect to the National Death Index, has been previously demonstrated. 21, 22 Each of the databases includes unique identifiers that allow merging of patient-level information across the databases.
Patient Population
The Patient Treatment File was used to identify 29 440 consecutive patients who were admitted with a principle diagnosis of AMI (ICD-9-CM 410) during the period October 1, 2003 to September 30, 2006 to all 144 VHA hospitals nationwide. For patients with more than 1 admission for AMI during the study period, we excluded (nϭ4561) those admissions that represented repeat AMI admissions during the study period. We then excluded patients without any VHA outpatient visits during months 13 to 24 before admission (nϭ3134), leaving a final study sample of 21 745 patients. We excluded patients without VHA visits in months 13 to 24 before their admission to ensure that patients in our sample were eligible for VHA care during the entire 12-month period before admission. Because the VHA does not maintain files accessible to investigators that identify individuals who are eligible for VHA care, this additional step ensured that individuals included in the analysis would have been eligible for VHA outpatient services a full 12 months before the date of admission. Separate analyses demonstrated that the excluded population had lower rates observed mortality and lower identification rates of psychiatric comorbidity.
Study Variables
Study end points included both 30-and 365-day mortality after admission and the receipt of coronary revascularization within 30 days of admission. ICD-9-CM procedure codes from the index hospitalization and from subsequent encounters were used to identify the receipt of revascularization by either percutaneous coronary intervention (PCI; 36.00 to 36.09) or coronary artery bypass graft surgery (CABG; 36.10 to 36.19) .
Primary independent variables included the presence of 5 psychiatric comorbid conditions, considered separately and in aggregate. These conditions were identified using 2 different methodological approaches: (1) ICD-9-CM secondary diagnosis codes from the index hospitalization; and (2) ICD-9-CM diagnosis codes captured during 1 or more outpatient encounters during the 12 months before admission. For both approaches, 5 major categories of psychiatric conditions that have been examined in prior AMI outcomes studies were identified: (1) depressive disorders (ICD-9-CM 296.20 to 36, 311, 300.4); (2) anxiety disorders (300.00 to 300.02, 293.84, 309.28, 309.21 to 309.23); (3) posttraumatic stress disorder (PTSD) (309.81); (4) bipolar disorders (296.00 to 296.06, 296.40 to 296.89); or (5) psychotic disorders, including schizophrenia and schizoaffective disorders (295). Other psychiatric conditions (eg, substance abuse disorders, personality disorders) were not examined, given the frequent overlap of these conditions with the 5 included conditions. Categorizations were based on all codes captured during the relevant encounters; thus, patients could be categorized with more than 1 condition.
Other variables that were used to describe the study population and to adjust for differences in the risk of mortality included: age; race (categorized as white, black, Hispanic, or missing); gender; marital status; VHA eligibility criterion (presence of a serviceconnected disability or indigent); comorbid medical conditions that are unlikely to reflect hospital complications, as defined using ICD-9-CM codes; 23 mechanical ventilation on day of admission; location of infarction; 24 and results of 9 selected laboratory tests (serum creatinine, blood urea nitrogen, albumin, total bilirubin, glucose, sodium, and troponin [both subtypes I and T], white blood cell count, and hemoglobin). All laboratory tests were captured within a 48-hour window surrounding the admission time. We chose the 48-hour window to optimize availability of laboratory data and to minimize laboratory scores that may reflect illness developing after the admission.
For each laboratory value (excluding troponin), we selected the most abnormal value, based on weights used in the APACHE (Acute Physiology and Chronic Disease Health Evaluation) III methodology. 25 Weights associated with each variable were then summed to create an overall laboratory severity score. Missing laboratory values were considered to be normal, consistent with the APACHE III methodology. A minimum of 4 nonmissing laboratory values were required to calculate a laboratory severity score. Patients with scores of 0 and for whom more than 4 values were missing were considered to have missing laboratory severity scores. Such patients had a higher observed mortality than other patients with scores of 0, and were thus examined in the analyses as a separate indicator variable. Model discrimination was improved by using a summary score rather than entering the laboratory values individually.
For troponin, we selected the most abnormal subtype I and T value for each patient. We then standardized values for each subtype by creating percentile ranks (1-100). For patients with values for both subtypes, we used the subtype value with the highest percentile rank. Percentile ranks were then classified into 4 categories of increasing risk, based on empirical associations with 30-day morality. Patients with missing values for both troponin I and T were examined separately in analyses.
Lastly, the use of coronary catheterization within 30 days of admission was identified using ICD-9-CM codes (37.22 to 37.23, 29, 88.53 to 88.57).
Analysis
The analysis consisted of several steps. First, agreement between psychiatric comorbidities measured by inpatient secondary diagnosis codes and outpatient diagnosis codes were measured using the statistic. Second, bivariate relationships between the presence of psychiatric comorbidity (as determined by both inpatient and outpatient diagnosis codes) and other demographic and clinical characteristics, mortality, and receipt of catheterization and revascularization were determined using the 2 or t tests. Third, other demographic and clinical factors that were associated (PϽ0.05) with the risk of 30-day or 365-day mortality and receipt of revascularization within 30 days were identified. Fourth, these variables (with the exception of psychiatric comorbidities) were then entered into stepwise multivariable regression analyses to identify independent (PϽ0.01) predictors of mortality, catheterization, and revascularization. (Variables included in the risk-adjustment models for 30-and 365-day mortality and their associated odds ratios are included in the supplemental materials.) These analyses used logistic regression to model mortality and proportional hazards to model receipt of coronary catheter-ization and revascularization, censoring patients who died within 30 days of admission. In the multivariable analyses, laboratory severity scores and troponin percentile ranks were categorized into discrete ranges that maximized associations with mortality and analyzed as separate (n-1) indicator variables; patients with missing values were analyzed as separate indicator variables.
Next, variables from the multivariable risk-adjustment models were entered in separate generalized estimating equations (GEE) or proportional hazards models that included indicator variables either for psychiatric comorbidity for all conditions in aggregate or for individual conditions. The GEE models used an exchangeable working correlation matrix in accounting for the clustering of patients within hospitals; proportional hazards models used robust sandwich covariance matrix estimators to account for clustering. Analyses to test the proportional hazards assumption found no interactions between terms between psychiatric comorbidity and the time-to-event. Coefficients associated with the psychiatric comorbidity indicator variables were used to estimate adjusted odds of death or the hazard revascularization. Separate analyses were conducted for psychiatric comorbidities identified using inpatient secondary diagnoses and outpatient diagnoses. Models examining mortality did not include the use of revascularization, given the potential endogeneity of revascularization and mortality.
Lastly, analyses were conducted in which patients with psychiatric comorbidity were classified into 3 exclusive groups depending on whether the comorbidity was identified by (1) both outpatient and inpatient diagnoses, (2) outpatient diagnosis alone, and (3) inpatient diagnosis alone. The risk of death in these patients was compared to patients without psychiatric comorbidity identified by either method.
The authors had full access to and take full responsibility for the integrity of the data. All authors have read and agree to the manuscript as written. All analyses were conducted using SAS statistical software version 9.1. The study was approved by the both the University of Iowa Institutional Review Board and the Research and Development Committee at the Iowa City VHA Medical Center.
Results
Overall, study subjects had a mean age (SD) of 68.5 (11.6) years and 98% were male. Sixty-three percent of patients were white and 12% were black; race was missing in 24%. Psychiatric comorbidity was identified in 10% (nϭ2285) of patients using inpatient secondary diagnosis codes and 24% (nϭ5225) of patients using prior outpatient diagnosis codes. Rates of identifying individual psychiatric conditions were also higher using outpatient codes than inpatient codes for each of the 5 conditions ( Figure 1 ).
Patients with psychiatric comorbidity, as identified by inpatient or outpatient diagnoses were younger, had lower mean laboratory severity scores, were less likely to be married and to have congestive heart failure, but were more likely to have chronic obstructive pulmonary disease (Table  1) . Mean troponin I and T values were similar in patients with and without psychiatric comorbidity, although the mean predicted probabilities of 30-day and 365-day death were lower in patients with psychiatric comorbidity identified by either approach.
The agreement between the identification of patients with psychiatric comorbidity, as identified by inpatient diagnosis codes and outpatient diagnosis codes was fair 26 (ϭ0.34 [PϽ0.001]). Of the 5225 patients identified by outpatient diagnosis codes, 31% (nϭ1625) also were identified by inpatient diagnosis codes, whereas of the 2287 patients identified by inpatient diagnosis codes 71% (nϭ1625) also had an outpatient diagnosis code. statistics for identifying individual conditions were 0.22 (PϽ0.001) for depression, 0.15 (PϽ0.001) for anxiety, 0.40 (PϽ0.001) for PTSD, 0.44 (PϽ0.001) for bipolar disorder, and 0.56 (PϽ0.001) for psychosis.
Patients with psychiatric comorbidity identified by inpatient diagnosis codes had lower unadjusted rates for both 30-day (6.4% versus 12.2% [Pϭ0.001]) and 365-day (16.3% versus 26.7% [PϽ0.001]) mortality than patients without psychiatric comorbidity. Patients with psychiatric comorbidity identified by outpatient diagnosis also had lower unadjusted rates for 365-day (23.4% versus 26.3% [PϽ0.001]) than patients without psychiatric comorbidity, but similar unadjusted 30-day (10.9% versus 11.9% [Pϭ0.05]) mortality. The differences between the associations with mortality based on inpatient and outpatient diagnoses were generally consistent in analyses of individual psychiatric conditions ( Table 2) .
In GEE analyses, the adjusted odds of death were similar in patients identified by inpatient diagnoses for both 30-day (odds ratio [OR], 0.89; 95% CI, 0.69 to 1.01; Pϭ0.08) and 365-day (OR, 0.93; 95% CI, 0.82 to 1.06; Pϭ0.29), but were higher among patients identified by outpatient diagnoses for both 30-day (OR, 1.19; 95% CI, 1.09 to 1.30; PϽ0.001) and 365-day (OR, 1.12; 95% CI, 1.03 to 1.22; Pϭ0.007) mortality. These associations were generally consistent in analyses of individual conditions, with the exception of the higher risk associated with anxiety disorders as identified by inpatient diagnoses (Figure 2 ). Additional analyses found that the adjusted odds of death for patients who were identified by either inpatient or outpatient diagnoses was higher for both 30-day (OR, 1.16; 95% CI, 1.06 to 1.27 [Pϭ0.002]) and 365-day (OR, 1.11; 95% CI, 1.02 to 1.21 [Pϭ0.01]) mortality.
To further understand the differences in mortality between outpatient and inpatient diagnoses, separate analyses examined associations in patients who were identified as having psychiatric comorbidities by both approaches or by one of the approaches but not the other (Table 3 ). These analyses found the highest risks of death in patients with psychiatric comorbidity identified only by outpatient diagnoses. In contrast, patients with psychiatric comorbidity identified by both outpatient and inpatient diagnoses had similar mortality as patients without inpatient or outpatient diagnoses.
The receipt of cardiac catheterization within 30 days of admission was higher in patients with psychiatric comor- In proportional hazards regression analyses, adjusting for age, illness severity, and comorbidity, the receipt of revascularization was lower in patients with psychiatric illness identified by outpatient diagnoses (hazard ratio [HR], 0.92; 95% CI, 0.85 to 0.98; Pϭ0.02), but was similar among patients with inpatient psychiatric diagnoses (HR, 1.00; 95% CI, 0.92 to 1.09; Pϭ0.91). Lastly, in analyses restricted to patients who underwent cardiac catheterization, the receipt of revascularization was similar in patients with psychiatric comorbidity, based on both outpatient (HR, 0.99; 95% CI, 0.92 to 1.07; Pϭ0.81) and inpatient (HR, 1.06; 95% CI, 0.96 to 1.18; Pϭ0. 23) diagnoses.
Discussion
The current study compared associations between psychiatric comorbidity and AMI outcomes that were derived using 2 alternative methods of identifying psychiatric comorbidity form administrative data in a cohort of veterans. We emphasize the following 3 findings. First, rates of psychiatric comorbidity differed depending on the identification approach and were substantially higher using diagnosis codes from prior outpatient encounters than secondary diagnosis codes from inpatient admissions. Moreover, the rates of psychiatric comorbidity found using prior outpatient diagnoses were more consistent with estimates of psychiatric illness (eg, depression) in AMI patients in prospective or cross-sectional studies that used patient interviews to identify such conditions. 3, [27] [28] [29] Second, patients identified by secondary inpatient codes tended to have lower severity, as exemplified by lower overall predicted mortality rates, lower rates of most comorbidities, and lower laboratory severity scores.
Third, associations between psychiatric comorbidity and mortality and receipt of revascularization differed among patients identified using outpatient and inpatient diagnoses. For example, patients identified from prior outpatient encounters had a modestly elevated risk of both 30-day and 365-day adjusted mortality, whereas patients identified by secondary inpatient diagnosis codes had similar 30-and 365-day adjusted mortality as patients without such codes.
The differences in identification rates, differences in patient characteristics, and the different associations with AMIrelated outcomes suggest that these approaches may be identifying somewhat different illness constructs.
The lack of an association between AMI related outcomes and patients identified by inpatient codes may represent several possibilities. First, secondary inpatient codes may be more likely to represent incident (new or acutely recognized) psychiatric illness associated with the admission illness, although, to our knowledge, no studies have specifically examined this possibility. Second, secondary inpatient codes may be more likely to represent transient or less severe psychiatric illness or to represent more remote psychiatric disease. Such conditions would have less prognostic or disease management implications than ongoing psychiatric disease. However, one exception to this finding was the higher risk of death associated with an inpatient secondary diagnoses of anxiety. This finding may indicate that symptoms of anxiety are a marker of more severe disease, undertreated cardiac ischemia, or patients' awareness of a more complicated hospital course. This explanation has received some support by Moser et al, 30 who reported that Table 3 
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AMI patients with higher levels of measured anxiety for patients had increased rates of cardiac complications (eg, arrhythmias, ventricular fibrillation, ongoing ischemia, and reinfarction).
In contrast, patients identified by outpatient psychiatric diagnoses in the prior 12 months may be more likely to have chronic or unresolved illnesses, which, in turn, may impact outcomes of acute medical conditions by decreasing rates of dietary and medication adherence, poorer disease management skills, and higher rates of tobacco use and other substance abuse. [31] [32] [33] It is possible that such patients may be at higher risk of adverse events after AMI.
Finally, secondary inpatient diagnosis codes for psychiatric comorbidity may be a marker for patients with less complicated hospital courses or with less comorbid illness. This may reflect the fixed number of secondary diagnosis codes that are captured in administrative data and the possibility that psychiatric comorbidities are less likely to be captured in the presence of other complex diagnoses or treatment complications. This possibility is supported by Finlayson et al, 34 who, counterintuitively, found lower mortality associated with diabetes, prior AMI, and chronic obstructive lung disease among patients undergoing pancreaticoduodenectomy or abdominal aneurysm repair. Other studies by Iezzoni et al 35 and Jencks et al 36 have made similar observations in medical populations.
Our findings of lower disease severity among patients with psychiatric comrobidity identified by secondary inpatient codes are consistent with 2 recent studies by Druss et al who analyzed administrative supplemented by clinical data collected in the Cooperative Cardiovascular Project. These studies found that individuals with psychiatric comorbidity, identified by secondary diagnosis codes, had lower predicted mortality, lower rates of many medical comorbidities and shock, and lower laboratory severity. 14, 16 In contrast, in a study of younger privately insured patients admitted with AMI, Jones et al 19 found that patients with psychiatric comorbidity, as identified by prior outpatient claims, had either similar or higher rates of most medical comorbidities (eg, peripheral vascular disorders, hypertension, chronic obstructive pulmonary disease, obesity, neurological disorders).
Finally, the lower rate of psychiatric comorbidity we found using inpatient secondary diagnosis codes is also consistent with the results of earlier studies of AMI that relied either on secondary inpatient 14, 16, 17 codes or prior outpatient diagnosis codes 19 to identify psychiatric conditions. Importantly, the current study is the first study to demonstrate the differences in rates of identification in the same patient population and the first to specifically examine whether associations between psychiatric comorbidity and AMI outcomes depend on the method of identifying psychiatric comorbidity.
It is important to acknowledge several potential limitations. First, our findings are based on a largely older male veteran population and may not be generalizable to females or other non-VHA populations. Generalizability may also be affected by potential selection biases related to unique benefits (eg, compensation for service related injuries, medication prescription benefits) offered by the VHA healthcare system. Second, our use of claims data may underestimate rates of psychiatric comorbidity; as such illnesses are likely to be underdiagnosed. Additionally, our use of claims data cannot estimate the acuity or severity of the psychiatric comorbidity and may be subject to misdiagnosis between PTSD and depression. For example, among patients with an outpatient diagnosis of PTSD, only 43% had a concomitant diagnosis of depression, notably lower than rates reported in some studies of veterans. 37, 38 Third, the effect sizes of the associations between psychiatric comorbidity and mortality that we observed were relatively modest and somewhat lower than the effects observed in prior prospective studies of depression and AMI related mortality. 1, 2, 4 Fourth, the sensitivity and specificity of ICD-9-CM codes in administrative databases may vary across individual diagnosis. 39, 40 Formal studies comparing accuracy of administrative data to other clinical data has found varying levels of agreement. 35, 41, 42 Nevertheless, much work has used administrative data to examine the quality of care 42 including several studies of veterans. [43] [44] [45] Moreover, work by Krakauer et al 46 and Ash et al 47 suggest that claims data may yield similar associations with mortality as data abstracted from patients medical records. Moreover, our models were further strengthened by including specific cardiac injury markers and other general laboratory data.
Finally, the exclusion of patients who did not have a visit in months 13 to 24 before the admission may have excluded some previously healthy VA users who did not have any outpatient visits in the prior 24 months or patients who only intermittently use the VA.
Despite these limitations, the current study holds implications for future research and policy. First, although the different approaches of identifying psychiatric comorbidity may identify different disease constructs, the low rates of psychiatric comorbidity identified by secondary diagnosis suggests that such diagnoses may have limited sensitivity. Moreover, the somewhat different associations with mortality and revascularization suggest that inpatient secondary diagnosis codes should not be used in isolation in studies to examine the prognostic effects of psychiatric comorbidities on outcomes of hospitalization or in the development of risk-adjustment models to standardize hospital outcomes for AMI and other acute conditions. Ideally, studies using administrative data to study psychiatric illnesses should examine multiple approaches for ascertaining comorbidity. Second, the current findings highlight the need for more in-depth studies to examine the clinical complexity and chronicity of psychiatric illness that is detected using diagnoses from prior outpatient encounters and, perhaps most importantly, using inpatient secondary diagnosis codes. Such work should clearly examine associations of these conditions with important outcomes.
Finally, this work emphasizes that, despite a growing awareness about the impact of psychiatric illness on AMI outcomes and possible mediators of such differences 14, 16 differences in outcomes may persist. These differences, in turn, may represent opportunities for targeting strategies to improve hospital care.
In conclusion, as the recognition of psychiatric comorbidity improves with better screening approaches and a higher public awareness, the monitoring of health care outcomes will become increasingly important. It is likely that much of this work will continue to use administrative data. However, in relying on administrative data, both investigators and policy makers should encourage the use of claims data from both outpatient and inpatient encounters to identify psychiatric illness. Moreover, in the absence of studies of the sensitivity and specificity of different identification methods, both parties should remain circumspect in interpreting findings that rely on secondary inpatient codes for identifying psychiatric comorbidity.
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